Literature DB >> 28057446

Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer.

Su Youn Nam1, Seong Woo Jeon2, Hyun Seok Lee1, Yong Hwan Kwon1, Haeyoon Park1, Jin Woo Choi1.   

Abstract

BACKGROUND: Although the pepsinogen I/II (PGI/II) ratio after Helicobacter pylori eradication is recovered at short-term follow-up, long-term follow-up studies of PGI/II are rare.
METHODS: A total of 773 patients with gastric cancer who underwent endoscopic resection and pepsinogen and H. pylori tests were enrolled. H. pylori was eradicated in these patients. Endoscopic and pepsinogen tests were performed every year. A low PGI/II ratio was defined as ≤3.
RESULTS: The PGI/II ratio was higher in non-infected patients (n=275, 4.99) than infected patients (n=498, 3.53). After H. pylori eradication, the PGI/II ratio increased to 5.81 and 5.63 after 1 and 2 years (each p<0.05). The PGI/II ratio in the non-eradication group decreased to 3.94 and 2.75 after 1 and 2 years. The PGI/II ratio in the H. pylori eradication group became similar to that of the H. pylori-negative group at 3 (4.48 vs. 4.34), 4 (4.88 vs. 4.34), and 5 years (4.89 vs. 4.23). The adjusted odds ratios for a lower PG I/II ratio in the non-eradication group compared to the eradication group were 4.78 (95% CI 2.15-10.67) after 1year and 8.13 (95% CI 2.56-25.83) after 2 years.
CONCLUSIONS: After H. pylori eradication, the PGI/II ratio increased and was similar to that of H. pylori-negative controls for up to 5 years of follow-up.
Copyright © 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Eradication; Helicobacter pylori; Long term follow-up; Pepsinogen

Mesh:

Substances:

Year:  2016        PMID: 28057446     DOI: 10.1016/j.dld.2016.12.016

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  2 in total

1.  Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis.

Authors:  Lingli Chen; Jianfeng Hong; Renjing Hu; Xiaomei Yu; Xindong Chen; Shaoxiong Zheng; Yuan Qin; Xiumei Zhou; Yigang Wang; Liping Zheng; Hongming Fang; Pengfei Liu; Biao Huang
Journal:  Cancer Manag Res       Date:  2021-10-09       Impact factor: 3.989

2.  Analysis of long-term serological and histological changes after eradication of Helicobacter pylori.

Authors:  Kensuke Fukuda; Masaaki Kodama; Kazuhiro Mizukami; Kazuhisa Okamoto; Ryo Ogawa; Yuka Hirashita; Masahide Fukuda; Kazumi Togo; Osamu Matsunari; Tadayoshi Okimoto; Kazunari Murakami
Journal:  J Clin Biochem Nutr       Date:  2022-03-31       Impact factor: 3.179

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.